793.74 USD
▲+12.25+1.57%
盘后 788.00 0.00%
2026-09-14
市值
$77.30B
市盈率
19.14
EPS
40.43
股息率
0.49%
52 周区间
541.00 – 859.34
成交量
591.29K
Beta
0.19
目标价
849.32
52W 低 541.0052W 高 859.34
价格走势
公司简介
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent ...
关联新闻
- US FDA approves Regeneron's rare bone disorder drug
The U.S. FDA on Wednesday approved Regeneron's experimental drug for a rare genetic disorder after it significantly reduced abnormal bone formation in certain soft tissues.